Lead article
Complex chromosomal translocations in the Philadelphia chromosome leukemias: Serial translocations or a concerted genomic rearrangement?

https://doi.org/10.1016/0165-4608(91)90145-KGet rights and content

Abstract

Joining of the BCR and ABL genes is an essential feature of the group of human leukemias characterized by the Philadelphia chromosome and there is recent evidence that the human BCR-ABL fusion gene induces leukemia in experimental animals. Joining of these two genes is the result of cytogenetic translocation, usually the t(9;22)(q34;q11), but sometimes of more complex translocations involving one or more chromosomes in addition to chromosomes 9 and 22. The leukemic cells of some patients carry the BCR-ABL fusion gene but have an apparently normal karyotype. Recent studies show that these cells conceal complex chromosome rearrangements.

Because the BCR-ABL fusion gene appears to be the result of cytogenetic rearrangement in all cases of these leukemias, the causes and mechanism of chromosome rearrangement will be relevant to the development of leukemia in man. We examine mechanisms of chromosome rearrangement and propose that both simple and complex chromosome translocations result from a single, though sometimes complex, interchange event.

References (38)

  • J Groffen et al.

    Philadelphia chromosome translocation

  • N Heisterkamp et al.

    Acute leukaemia in bcr/abl transgenic mice

    Nature

    (1990)
  • GQ Daley et al.

    Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome

    Science

    (1990)
  • MA Kelliher et al.

    Induction of a chronic myelogenous leukemia-like syndrome in mice with v-abl and BCR/ABL

  • M De Braekeleer

    Variant Philadelphia translocations in chronic myeloid leukemia

    Cytogenet Cell Genet

    (1987)
  • F Mitelman

    Catalog of Chromosome Aberrations in Cancer

  • AA Sandberg

    The Chromosomes in Human Cancer and Leukemia

  • R Kurzrock et al.

    Rearrangement in the breakpoint cluster region and the clinical course in Philadelphia-negative chronic myelogenous leukemia

    Ann Intern Med

    (1986)
  • CM Morris et al.

    Genomic diversity correlates with clinical variation in Ph1-negative chronic myeloid leukemia

    Nature

    (1986)
  • Cited by (58)

    • Overview of clinical and genetic features of CML patients with variant Philadelphia translocations involving chromosome 7: A case series

      2021, Leukemia Research
      Citation Excerpt :

      Then a second translocation occurs with an additional chromosome or chromosomes. Translocations formed by the two-step mechanism are more complex [7–9]. The variant Ph translocations may involve many other chromosomes.

    • Molecular cytogenetic characterization of variant Philadelphia translocations in chronic myeloid leukemia: genesis and deletion of derivative chromosome 9

      2009, Cancer Genetics and Cytogenetics
      Citation Excerpt :

      Variant Ph chromosome translocations may be caused by insertion or other mechanisms [4,5]. There is open debate about the formation of these rearrangements: some researchers [6–9] have invoked a one-step mechanism, wherein chromosome breakage occurs on three different chromosomes simultaneously in a three-, four-, or five-way translocation, then reciprocally rejoin at the same time. Others [10,11] have suggested a two-step mechanism, in which a standard two-way t(9;22) is followed by subsequent translocation involving additional chromosomes, and some recent studies [3,9] have reported both mechanisms in the same patient.

    • Mechanisms of genesis of variant translocation in chronic myeloid leukemia are not correlated with ABL1 or BCR deletion status or response to imatinib therapy

      2008, Cancer Genetics and Cytogenetics
      Citation Excerpt :

      To date, two main mechanisms in the formation of variant translocation have already been described. The one-step mechanism has been referred to a simultaneous swap among the three (or more) chromosomes involved in translocation [5,6,20]. It is illustrated by one fusion, two red, and two green signals (1F2G2R).

    • Complex chromosomal rearrangements in patients with chronic myeloid leukemia

      2006, Cancer Genetics and Cytogenetics
      Citation Excerpt :

      Masked Ph chromosomes can be found in cases with a normal karyotype, as a result of a cryptic rearrangement, or in patients with complex changes where the typical t(9;22)(q34;q11) is not detectable by G-banding [2]. Variant Ph translocations are cytogenetically classified as simple (involving chromosome 22 and one chromosome other than 9 [3]) or complex (involving chromosomes 9, 22, and one or more other chromosomes [4]). The segment from the third chromosome is usually translocated to the band 9q34, whereas the 22q11∼qter segment (including the 3′BCR region) moves to the breakpoint of the third chromosome [5,6].

    • Studies of complex Ph translocations in cases with chronic myelogenous leukemia and one with acute lymphoblastic leukemia

      2006, Cancer Genetics and Cytogenetics
      Citation Excerpt :

      Complex translocations may be caused by different mechanisms. Some variant translocations are formed by multiple simultaneous breaks, and some arise as a result of 2 or more consecutive genetic events [14–17]. In our series, all chromosomally abnormal cells showed the complex variant t(9;22;V) at the time of diagnosis, suggesting that it was originated in a stem cell.

    View all citing articles on Scopus

    This project was supported by the Cancer Society of New Zealand, its Canterbury-Westland Division, and the WH Travis Trust.

    View full text